MDCX Stock Overview
Medicus Pharma Ltd., a pharmaceutical holding company, through its subsidiary Skinject Inc., engages in the developing and commercializing novel non-invasive treatment for basal cell and squamous cell skin cancer.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medicus Pharma Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.17 |
| 52 Week High | CA$3.05 |
| 52 Week Low | CA$0.31 |
| Beta | 0 |
| 1 Month Change | -7.27% |
| 3 Month Change | -27.42% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 8.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDCX | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 2.8% | 0.6% | 0.9% |
| 1Y | n/a | -35.7% | 8.8% |
Return vs Industry: Insufficient data to determine how MDCX performed against the Canadian Biotechs industry.
Return vs Market: Insufficient data to determine how MDCX performed against the Canadian Market.
Price Volatility
| MDCX volatility | |
|---|---|
| MDCX Average Weekly Movement | 6.9% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: MDCX's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MDCX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Raza Bokhari | medicuspharma.com |
Medicus Pharma Ltd., a pharmaceutical holding company, through its subsidiary Skinject Inc., engages in the developing and commercializing novel non-invasive treatment for basal cell and squamous cell skin cancer. It uses its patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The company was founded in 2015 and is based in Toronto, Canada.
Medicus Pharma Ltd. Fundamentals Summary
| MDCX fundamental statistics | |
|---|---|
| Market cap | CA$35.05m |
| Earnings (TTM) | CA$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MDCX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDCX income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$0 |
| Earnings | CA$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MDCX perform over the long term?
See historical performance and comparison